Delivery Order SPE2DB20D2104-SPE2DB24FR48H
Award Date 12/5/23
Potential Completion Date 12/6/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,641.93, is for the delivery of Xulane 150-35 mcg/day patch 3s, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of February 15, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,392.42, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $13,904.80, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This is a firm fixed-price delivery order contract with a period of performance through December 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The contract, valued at $4,440.37, is a firm fixed-price delivery order with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,355.75 firm fixed-price delivery order is for the pharmaceutical product Xulane 150-35 mcg/day patch, a contraceptive medication. The contract has an ultimate completion date of May 22, 2023 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, valued at $3,162.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xulane 150-35 mcg/day patch, a contraceptive product, and is classified as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,723.81, is a delivery order contract for the supply of XULANE 150-35 MCG/DAY PATCH 3S medical patches. The contract has a ceiling value of $3,723.81 and a completion date of April 3, 2025. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,486.10, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award, valued at $2,854.52, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of December 6, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,255.82, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of July 26, 2024 and is a Firm Fixed Price Delivery Order contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...